Belvedere Trading’s T-REX 2X Inverse CRCL Daily Target ETF CRCD Stock Holding History

Belvedere Trading’s Portfolio CRCD Stock Details CRCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$99.9K	Buy	14,800 +5,200	+54%	+$143K	﹤0.01%	515
2025 Q4	$330K	Buy	+9,600	New	+$291K	﹤0.01%	356

Other funds holding CRCD

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Belvedere Trading's CRCD Position: Q1 2026 in Review

Belvedere Trading sold out of T-REX 2X Inverse CRCL Daily Target ETF (CRCD) in Q1 2026, closing a stake of 6,865 shares — an estimated $188K sold.

Belvedere Trading first reported a position in CRCD in Q4 2025 and held it in 1 quarter. The position peaked at $236K in Q4 2025. 8 funds tracked by Wall St. Rank hold CRCD as of Q1 2026.

Belvedere Trading reported no remaining T-REX 2X Inverse CRCL Daily Target ETF position as of Q1 2026 after selling out during the quarter.
Belvedere Trading sold 6,865 T-REX 2X Inverse CRCL Daily Target ETF shares in Q1 2026, an estimated $188K.
Belvedere Trading first reported a position in T-REX 2X Inverse CRCL Daily Target ETF in Q4 2025 and held it in 1 quarter.
Belvedere Trading's T-REX 2X Inverse CRCL Daily Target ETF position peaked at $236K in Q4 2025.
8 funds tracked by Wall St. Rank held T-REX 2X Inverse CRCL Daily Target ETF as of Q1 2026.

Based on Belvedere Trading's 13F filing for Q1 2026, filed 12 May 2026.